Skip to Content

Butabarbital Pregnancy and Breastfeeding Warnings

Butabarbital is also known as: Busodium, Butisol Sodium

Medically reviewed on Sep 13, 2018

Butabarbital Pregnancy Warnings

Butabarbital has been assigned to pregnancy category D by the FDA. Use of barbiturates during pregnancy has been associated with a higher incidence of fetal abnormalities. Neonatal barbiturate withdrawal symptoms have been reported in infants whose mothers took barbiturates during pregnancy. In addition, administration of sedative-hypnotic barbiturates during labor may cause respiratory depression in the newborn. There are no controlled data in human pregnancy. Patients who receive butabarbital during pregnancy should be advised of the potential hazard to the fetus.

See references

Butabarbital Breastfeeding Warnings

Butabarbital is excreted into human breast milk in small amounts and should be administered with caution to nursing mothers.

See references

References for pregnancy information

  1. "Product Information. Butisol Sodium (butabarbital)." Meda Pharmaceuticals, Somerset, NJ.

References for breastfeeding information

  1. "Product Information. Butisol Sodium (butabarbital)." Meda Pharmaceuticals, Somerset, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide